Status:
COMPLETED
Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Opioid Use
Opioid-use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to determine whether referral to the Bridge Clinic reduces overall index hospital length of stay when compared to direct referral to a long-term outpatient addiction provider for patie...
Eligibility Criteria
Inclusion
- Inpatients at VUH with active OUD being considered for MAT.
- Patient accepting a transitional prescription for buprenorphine-naloxone or IM naltrexone whose outpatient plans are not fixed
Exclusion
- Deemed ineligible for referral to outpatient Bridge Clinic by the Addiction Consult Team (examples include but are not limited to patients with severe, active co-occurring psychiatric disorders requiring a higher level of psychiatric care or patients for whom methadone maintenance is deemed the best choice of MAT).
- Patients previously randomized in this study.
Key Trial Info
Start Date :
November 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2022
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT04084392
Start Date
November 25 2019
End Date
January 18 2022
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232